Charlotte Nicod joined Flagship Pioneering in 2020 after completing the Flagship Pioneering Fellowship. Charlotte works with a team of entrepreneurial scientists to drive ventures from origination to value imagining, creating and advancing the next generation of Flagship’s multi-product bioplatform companies.
Charlotte earned her Ph.D. in Systems Biology from ETH Zurich in Professor Ruedi Aebersold’s laboratory. During her doctoral studies, she worked on developing and applying mass-spectrometry-based methods to investigate protein-protein interactions in the context of infectious diseases. This work, in collaboration with the Swiss Tropical Health Institute, focused on how Mycobacterium tuberculosis modulates host immunity by hijacking cellular pathways. While pursuing her academic research, Charlotte was also involved in multiple entrepreneurial activities including participating in startup contests, organizing entrepreneurial competitions in collaboration with MIT and the National University of Singapore, and conferences for Systems Biology graduate students across multiple universities.
Charlotte obtained her B.S. and M.S. in Biology and Molecular Health Sciences from the University of Lausanne and ETH Zurich. During her undergraduate studies, she also interned at Moderna Therapeutics.